StockWatch
·
Pharmaceuticals
Quarterly Result27 Mar 2026, 02:38 pm

Sunil Healthcare Ltd. Announces Closure of Trading Window for Q4 FY 2025-26 Results

AI Summary

Sunil Healthcare Ltd. has announced the closure of the trading window for all designated persons and their immediate relatives, as per the Company's Code of Conduct, from April 01, 2026 till 48 hours after the declaration of Audited Financial results for the 4th quarter/Financial year 2025-26 ended on March 31, 2026. This decision is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the amendments made in 2018.

Key Highlights

  • Trading window closure for designated persons and their immediate relatives from April 01, 2026
  • Closure continues till 48 hours after the declaration of Q4 FY 2025-26 results
  • Decision in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and 2018 amendments
  • All persons in receipt of insider information directed not to trade during the closure period
  • Code of conduct for insider trading available at https://www.sunilhealthcare.com/uploads/filemanager/3818code-of-conduct-for-Insider-trading.pdf